 |
| Frank Niemeir/AJC |
| Harold Shlevin, CEO of Tikvah Therapeutics, the Atlanta biotechnology company that plans to market the anti-anxiety drug within a few years, says the potential market is enormous. |
Sponsored Gallery
Photos by Harry Norman, REALTORS®
Home Gallery:
Atlanta’s finest real estate for sale
Harry Norman, REALTORS®: Resort-style living and leisurely pursuits.
Services »
